AEON Biopharma (AEON) Current Assets (2020 - 2026)
AEON Biopharma (AEON) posted Current Assets of $3.4 million for Q4 2025, down 54.16% sequentially from $7.4 million in Q3 2025, and up 113.71% YoY from $1.6 million in Q4 2024.
AEON Biopharma (AEON) Current Assets (2020 - 2026) Analysis & Trends
AEON Biopharma has reported Current Assets for 6 years, with the latest figure at $3.4 million in Q4 2025.
- Quarterly Current Assets rose 113.71% year-over-year to $3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (up 113.71% YoY) and the FY2025 annual result came in at $3.4 million, up 113.71% from the prior year.
- Current Assets eased to $3.4 million in Q4 2025 per AEON's latest filing, from $7.4 million in the prior quarter.
- Over five years, Current Assets peaked at $16.9 million in Q3 2023 and troughed at $166171.0 in Q3 2022.
- A 5-year average of $4.2 million and a median of $2.3 million in 2021 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2024: Current Assets surged 10076.87% in 2023, then sank 85.98% in 2024.
- Over 5 years, Current Assets stood at $835224.0 in 2021, then soared by 1077.89% to $9.8 million in 2022, then sank by 36.76% to $6.2 million in 2023, then slumped by 74.45% to $1.6 million in 2024, then jumped by 113.71% to $3.4 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $3.4 million, $7.4 million, and $10.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.76 Bn |
| 10 | AEON Biopharma | 9.91 Mn | 6.48 Mn | - | 3.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.99 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 10.26 Mn |
| Mar 31, 2025 | 12.32 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Jun 30, 2024 | 4.02 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 6.22 Mn |
| Sep 30, 2023 | 16.91 Mn |
| Jun 30, 2023 | 592,098.00 |
| Mar 31, 2023 | 542,378.00 |
| Dec 31, 2022 | 9.84 Mn |
| Sep 30, 2022 | 166,171.00 |
| Jun 30, 2022 | 248,294.00 |
| Mar 31, 2022 | 518,527.00 |
| Dec 31, 2021 | 835,224.00 |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 1.38 Mn |